The Department of Justice is seeking public input on the "distinct economic impacts" of its plan to reclassify pot. Big money is at stake. Read More
Marijuana Investing
The “next big thing” in the booming psychotropics industry? Tourist packages predicated on LSD, magic mushrooms, and other psychedelic drugs. Read More
We questioned one of the world’s top biotech investment strategists about the increasing monetization of psychedelics. Read More
The recent decision by the U.S. Drug Enforcement Administration (DEA) to shift cannabis to Schedule III is on its way to becoming reality. Read More
The DEA's reclassification of marijuana would substantially enhance the profitability and social acceptance of weed companies. Read More
According to news reports this week, the DEA intends to reevaluate restrictions on marijuana, recognizing its medical benefits. Read More
A new study released last week demolishes the cliche that marijuana turns its users into paranoid and lazy loafers. Read More
The Bay State is a microcosm of marijuana’s increasing popularity throughout the country, especially in customer-rich Northeastern states. Read More
A major pollster chose the global marijuana holiday as an opportune time to release new findings that confirm weed's increasing acceptance. Read More
The medical use of marijuana has skyrocketed in the U.S. in recent years, underscoring the vast growth potential of cannabis. Read More